Pages that link to "Q34787210"

The following pages link to Mechanisms that regulate silencing of gene expression from retroviral vectors (Q34787210):

Displaying 24 items.

• Postintegrative gene silencing within the Sleeping Beauty transposition system (Q28756070) (← links)
• Loss of T cell-mediated antitumor immunity after construct-specific downregulation of retrovirally encoded T-cell receptor expression in vivo (Q34727843) (← links)
• Gene therapy: theoretical and bioethical concepts (Q35212648) (← links)
• Isolation of mesenchymal stem cells (MSCs) from green fluorescent protein positive (GFP+) transgenic rodents: the grass is not always green(er) (Q35296805) (← links)
• Smad1 expands the hemangioblast population within a limited developmental window (Q35615848) (← links)
• High-frequency epigenetic repression and silencing of retroviruses can be antagonized by histone deacetylase inhibitors and transcriptional activators, but uniform reactivation in cell clones is restricted by additional mechanisms (Q35784937) (← links)
• Reactivation of Silenced WT1 Transgene by Hypomethylating Agents - Implications for in vitro Modeling of Chemoimmunotherapy (Q36056904) (← links)
• Efficient nonviral Sleeping Beauty transposon-based TCR gene transfer to peripheral blood lymphocytes confers antigen-specific antitumor reactivity. (Q36311669) (← links)
• Identification of cellular proteins that maintain retroviral epigenetic silencing: evidence for an antiviral response (Q36483968) (← links)
• Long-term gene expression in dividing and nondividing cells using SV40-derived vectors. (Q36685600) (← links)
• Feline immunodeficiency virus-mediated long-term transgene expression in undifferentiated retinal progenitor cells and its downregulation in differentiated cells (Q36992625) (← links)
• Lack of specific gamma-retroviral vector long terminal repeat promoter silencing in patients receiving genetically engineered lymphocytes and activation upon lymphocyte restimulation (Q37373008) (← links)
• Virion factors that target Daxx to overcome intrinsic immunity. (Q38122355) (← links)
• Dynamic and selective HERV RNA expression in neuroblastoma cells subjected to variation in oxygen tension and demethylation (Q38799073) (← links)
• Cell type-specific activation of the cytomegalovirus promoter by dimethylsulfoxide and 5-aza-2'-deoxycytidine (Q39281623) (← links)
• Effect of 17β-estradiol and flavonoids on the regulation of expression of newly identified oestrogen responsive genes in a rat raphe nuclei-derived cell line (Q39418617) (← links)
• Activation of CMV promoter-controlled glycosyltransferase and beta -galactosidase glycogenes by butyrate, tricostatin A, and 5-aza-2'-deoxycytidine (Q40428477) (← links)
• Retroviral vectors encoding ADA regulatory locus control region provide enhanced T-cell-specific transgene expression (Q41844097) (← links)
• Specific in vivo expression in type II pneumocytes of the Jaagsiekte sheep retrovirus long terminal repeat in transgenic mice (Q43152208) (← links)
• Use of transduced adipose tissue stromal cells as biologic minipumps to deliver levodopa for the treatment of neuropathic pain: possibilities and limitations (Q43297572) (← links)
• Mutation of CpGs in the murine stem cell virus retroviral vector long terminal repeat represses silencing in embryonic stem cells (Q44618313) (← links)
• Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver (Q45722297) (← links)
• Direct introduction of gene constructs into the pronucleus-like structure of cloned embryos: a new strategy for the generation of genetically modified pigs (Q48164475) (← links)
• Effect of trichostatin A and 5-Aza-2′-deoxycytidine on transgene reactivation and epigenetic modification in transgenic pig fibroblast cells (Q50521366) (← links)